Association between S100B levels and long-term outcome after aneurysmal subarachnoid hemorrhage: Systematic review and pooled analysis

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Lai, Pui Man Rosalind ^a   Du, Rose ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN S100B; BIOLOGICAL MARKER; S100B PROTEIN, HUMAN;

BLOOD VESSEL CLIP; BRAIN ANGIOGRAPHY; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN VASOSPASM; COIL EMBOLIZATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DOPPLER ECHOGRAPHY; GLASGOW OUTCOME SCALE; HUMAN; OUTCOME ASSESSMENT; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; REVIEW; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW; BLOOD; PATHOLOGY;

BIOMARKERS; HUMANS; PROGNOSIS; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; SUBARACHNOID HEMORRHAGE;

EID: 84962118457     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0151853     Document Type: Review

References (40)

1. King JT Jr. Epidemiology of aneurysmal subarachnoid hemorrhage. Neuroimaging clinics of North America. 1997;7(4):659-68. PMID: 9336491.
2. Frontera JA, Fernandez A, Schmidt JM, Claassen J, Wartenberg KE, Badjatia N, et al. Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke; a journal of cerebral circulation. 2009;40(6):1963-8. doi: 10.1161/STROKEAHA.108.544700 PMID: 19359629.
3. Kassell NF, Sasaki T, Colohan AR, Nazar G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke; a journal of cerebral circulation. 1985;16(4):562-72. PMID: 3895589.
4. Dorsch NW, King MT. A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage Part I: Incidence and effects. J Clin Neurosci. 1994;1(1):19-26. Epub 1994/01/01. PMID: 18638721.
5. Weir B, Grace M, Hansen J, Rothberg C. Time course of vasospasm in man. Journal of neurosurgery. 1978;48(2):173-8. doi: 10.3171/jns.1978.48.2.0173 PMID: 624965.
6. Coyne TJ, Loch Macdonald R, Christopher Wallace M. Angiographic vasospasm in a contemporary series of patients with aneurysmal subarachnoid haemorrhage. J Clin Neurosci. 1994;1(2):106-10. PMID: 18638739.
7. Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). The Lancet Neurology. 2011;10(7):618-25. doi: 10.1016/S1474-4422 (11) 70108-9 PMID: 21640651.
8. Cahill J, Zhang JH. Subarachnoid hemorrhage: is it time for a new direction? Stroke; a journal of cerebral circulation. 2009;40(3 Suppl):S86-7. doi: 10.1161/STROKEAHA.108.533315 PMID: 19064787; PubMed Central PMCID: PMC2743545.
9. Yuksel S, Tosun YB, Cahill J, Solaroglu I. Early brain injury following aneurysmal subarachnoid hemorrhage: emphasis on cellular apoptosis. Turkish neurosurgery. 2012;22(5):529-33. doi: 10.5137/1019-5149. JTN.5731-12.1 PMID: 23015327.
10. Blyth BJ, Farhavar A, Gee C, Hawthorn B, He H, Nayak A, et al. Validation of serum markers for bloodbrain barrier disruption in traumatic brain injury. Journal of neurotrauma. 2009;26(9):1497-507. doi: 10.1089/neu.2008-0738 PMID: 19257803; PubMed Central PMCID: PMC2822805.
11. Amiri M, Astrand R, Romner B. Can S100B Predict Cerebral Vasospasms in Patients Suffering from Subarachnoid Hemorrhage? Frontiers in neurology. 2013;4:65. doi: 10.3389/fneur.2013.00065 PMID: 23761779; PubMed Central PMCID: PMC3674401.
12. Kaneda K, Fujita M, Yamashita S, Kaneko T, Kawamura Y, Izumi T, et al. Prognostic value of biochemical markers of brain damage and oxidative stress in post-surgical aneurysmal subarachnoid hemorrhage patients. Brain research bulletin. 2010;81(1):173-7. doi: 10.1016/j.brainresbull.2009.10.020 PMID: 19887101.
13. Ducruet AF, Gigante PR, Hickman ZL, Zacharia BE, Arias EJ, Grobelny BT, et al. Genetic determinants of cerebral vasospasm, delayed cerebral ischemia, and outcome after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2010;30(4):676-88. doi: 10.1038/jcbfm.2009.278 PMID: 20068580; PubMed Central PMCID: PMCPMC2949164.
14. Rosalind Lai PM, Du R. Role of Genetic Polymorphisms in Predicting Delayed Cerebral Ischemia and Radiographic Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis. World Neurosurg. 2015;84(4):933-41 e2. doi: 10.1016/j.wneu.2015.05.070 PMID: 26074429.
15. Zaykin DV. Optimally weighted Z-test is a powerful method for combining probabilities in meta-analysis. Journal of evolutionary biology. 2011;24(8):1836-41. doi: 10.1111/j.1420-9101.2011.02297.x PMID: 21605215; PubMed Central PMCID: PMC3135688.
16. Bellapart J, Jones L, Bandeshe H, Boots R. Plasma endothelin-1 as screening marker for cerebral vasospasm after subarachnoid hemorrhage. Neurocritical care. 2014;20(1):77-83. doi: 10.1007/s12028-013-9887-1 PMID: 23921571.
17. Moritz S, Warnat J, Bele S, Graf BM, Woertgen C. The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage. Journal of neurosurgical anesthesiology. 2010;22(1):21-31. doi: 10.1097/ANA.0b013e3181bdf50d PMID: 20027011.
18. Jung CS, Lange B, Zimmermann M, Seifert V. CSF and Serum Biomarkers Focusing on Cerebral Vasospasm and Ischemia after Subarachnoid Hemorrhage. Stroke research and treatment. 2013;2013:560305. doi: 10.1155/2013/560305 PMID: 23509668; PubMed Central PMCID: PMC3590649.
19. Kay A, Petzold A, Kerr M, Keir G, Thompson E, Nicoll J. Decreased cerebrospinal fluid apolipoprotein E after subarachnoid hemorrhage: correlation with injury severity and clinical outcome. Stroke; a journal of cerebral circulation. 2003;34(3):637-42. doi: 10.1161/01. STR.0000057579.25430.16 PMID: 12624284.
20. Oertel M, Schumacher U, McArthur DL, Kastner S, Boker DK. S-100B and NSE: markers of initial impact of subarachnoid haemorrhage and their relation to vasospasm and outcome. J Clin Neurosci. 2006;13(8):834-40. doi: 10.1016/j.jocn. 2005.11.030 PMID: 16931022.
21. Pereira AR, Sanchez-Pena P, Biondi A, Sourour N, Boch AL, Colonne C, et al. Predictors of 1-year outcome after coiling for poor-grade subarachnoid aneurysmal hemorrhage. Neurocritical care. 2007;7(1):18-26. doi: 10.1007/s12028-007-0053-5 PMID: 17657653.
22. Sanchez-Pena P, Pereira AR, Sourour NA, Biondi A, Lejean L, Colonne C, et al. S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage. Critical care medicine. 2008;36(8):2267-73. doi: 10.1097/CCM.0b013e3181809750 PMID: 18596638.
23. Schick U, Dohnert J, Meyer JJ, Vitzthum HE. Prognostic significance of SSEP, BAEP and serum S-100B monitoring after aneurysm surgery. Acta neurologica Scandinavica. 2003;108(3):161-9. PMID: 12911458.
24. Siman R, Giovannone N, Toraskar N, Frangos S, Stein SC, Levine JM, et al. Evidence that a panel of neurodegeneration biomarkers predicts vasospasm, infarction, and outcome in aneurysmal subarachnoid hemorrhage. PloS one. 2011;6(12):e28938. doi: 10.1371/journal.pone.0028938 PMID: 22174930; PubMed Central PMCID: PMC3235169.
25. Weiss N, Sanchez-Pena P, Roche S, Beaudeux JL, Colonne C, Coriat P, et al. Prognosis value of plasma S100B protein levels after subarachnoid aneurysmal hemorrhage. Anesthesiology. 2006;104(4):658-66. PMID: 16571959.
26. Wiesmann M, Missler U, Hagenstrom H, Gottmann D. S-100 protein plasma levels after aneurysmal subarachnoid haemorrhage. Acta neurochirurgica. 1997;139(12):1155-60. PMID: 9479422.
27. Moews PC, Kretsinger RH. Refinement of the structure of carp muscle calcium-binding parvalbumin by model building and difference Fourier analysis. Journal of molecular biology. 1975;91(2):201-25. PMID: 1237625.
28. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. The international journal of biochemistry & cell biology. 2001;33(7):637-68. PMID: 11390274.
29. Moore BW. A soluble protein characteristic of the nervous system. Biochemical and biophysical research communications. 1965;19(6):739-44. PMID: 4953930.
30. Chaves ML, Camozzato AL, Ferreira ED, Piazenski I, Kochhann R, Dall'Igna O, et al. Serum levels of S100B and NSE proteins in Alzheimer's disease patients. Journal of neuroinflammation. 2010;7:6. doi: 10.1186/1742-2094-7-6 PMID: 20105309; PubMed Central PMCID: PMC2832635.
31. Otto M, Bahn E, Wiltfang J, Boekhoff I, Beuche W. Decrease of S100 beta protein in serum of patients with amyotrophic lateral sclerosis. Neuroscience letters. 1998;240(3):171-3. PMID: 9502231.
32. Calik M, Abuhandan M, Sonmezler A, Kandemir H, Oz I, Taskin A, et al. Elevated serum S-100B levels in children with temporal lobe epilepsy. Seizure. 2013;22(2):99-102. doi: 10.1016/j.seizure.2012.10. 012 PMID: 23146618.
33. Thelin EP, Johannesson L, Nelson D, Bellander BM. S100B is an important outcome predictor in traumatic brain injury. Journal of neurotrauma. 2013;30(7):519-28. doi: 10.1089/neu.2012.2553 PMID: 23297751.
34. Egea-Guerrero JJ, Murillo-Cabezas F, Gordillo-Escobar E, Rodriguez-Rodriguez A, Enamorado-Enamorado J, Revuelto-Rey J, et al. S100B protein may detect brain death development after severe traumatic brain injury. Journal of neurotrauma. 2013;30(20):1762-9. doi: 10.1089/neu.2012.2606 PMID: 23710646; PubMed Central PMCID: PMC3796324.
35. Rainey T, Lesko M, Sacho R, Lecky F, Childs C. Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: results using a single (24h) time-point. Resuscitation. 2009;80(3):341-5. doi: 10.1016/j.resuscitation. 2008.11.021 PMID: 19150161.
36. Weglewski A, Ryglewicz D, Mular A, Jurynczyk J. [Changes of protein S100B serum concentration during ischemic and hemorrhagic stroke in relation to the volume of stroke lesion]. Neurologia i neurochirurgia polska. 2005;39(4):310-7. PMID: 16096936.
37. Kaca-Orynska M, Tomasiuk R, Friedman A. Neuron-specific enolase and S 100B protein as predictors of outcome in ischaemic stroke. Neurologia i neurochirurgia polska. 2010;44(5):459-63. PMID: 21082487.
38. Herrmann M, Vos P, Wunderlich MT, De Bruijn CH, Lamers KJ. Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke; a journal of cerebral circulation. 2000;31(11):2670-7. PMID: 11062293.
39. Rosengart AJ, Schultheiss KE, Tolentino J, Macdonald RL. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke; a journal of cerebral circulation. 2007;38(8):2315-21. doi: 10.1161/STROKEAHA.107.484360 PMID: 17569871.
40. Sloan MA, Haley EC Jr., Kassell NF, Henry ML, Stewart SR, Beskin RR, et al. Sensitivity and specificity of transcranial Doppler ultrasonography in the diagnosis of vasospasm following subarachnoid hemorrhage. Neurology. 1989;39(11):1514-8. PMID: 2682350